×
About 10,100 results

ALLMedicine™ Erectile Dysfunction Center

Research & Reviews  3,014 results

Interactions between erectile dysfunction, cardiovascular disease and cardiovascular dr...
https://doi.org/10.1038/s41569-021-00593-6 10.1046/j.1464-410X.2002.02911.x 10.1016/j.sxmr.2018.06.005 10.1016/S0022-5347(17)34871-1 10.2174/138161208786898716 10.2164/jandrol.110.011338 10.1016/j.jacc.2019.03.010 10.1093/eurheartj/eht112 10.1093/eurheartj/ehw106 10.1097/HJH.0000000000002382 10.2174/138161209789206980 10.1016/S0140-6736(12)60520-0 10.1038/nrdp.2016.3 10.1016/S0302-2838(03)00307-5 10.1161/CIRCRESAHA.115.305364 10.1016/j.amjcard.2011.03.093 10.1161/HYPERTENSIONAHA.114.03369 10.1111/j.1743-6109.2010.01966.x 10.1016/j.jsxm.2015.11.014 10.1093/eurheartj/ehl341 10.1016/j.jacc.2020.03.081 10.1161/01.CIR.0000148821.97162.5E 10.1161/CIRCULATIONAHA.105.535435 10.1016/j.eururo.2007.08.004 10.1042/CS20200865 10.1093/ajh/hpaa143 10.1016/j.jacc.2015.12.005 10.1093/ajh/hps056 10.1016/j.jsxm.2018.06.012 10.1111/j.1743-6109.2010.02191.x 10.1016/j.jacc.2012.08.1016 10.23736/S0026-4725.20.05136-1 10.1080/14779072.2020.1745632 10.1001/archinte.166.2.207 10.1016/j.atherosclerosis.2009.05.005 10.1016/j.ahj.2007.03.024 10.1016/S0302-2838(03)00305-1 10.1093/eurheartj/ehl142 10.1093/eurheartj/eht308.957 10.1016/j.jsxm.2019.04.004 10.1097/00042307-200411000-00012 10.1016/j.eururo.2005.08.002 10.1053/euhj.1999.1763 10.1093/eurheartj/ehv557 10.1111/ijcp.12275 10.1002/clc.22530 10.1002/ehf2.12108 10.1111/j.2047-2927.2012.00048.x 10.1111/j.1743-6109.2009.01416.x 10.1111/j.1742-1241.2006.01274.x 10.1002/clc.20918 10.1111/j.1743-6109.2011.02350.x 10.1016/j.jsxm.2019.04.012 10.1016/j.eururo.2013.08.023 10.1001/jama.294.23.2996 10.1371/journal.pmed.1001372 10.1016/j.eururo.2011.02.008 10.1097/HJH.0000000000000877 10.1111/j.1743-6109.2010.01744.x 10.1016/j.jacc.2007.10.069 10.1016/j.jacc.2008.02.051 10.1016/j.jacc.2010.04.067 10.2337/dc13-0294 10.1371/journal.pone.0043673 10.1161/CIRCULATIONAHA.109.864199 10.1111/j.1743-6109.2009.01278.x 10.1038/ijir.2009.40 10.1111/j.1743-6109.2012.02826.x 10.1038/sj.ijir.3900472 10.1161/CIRCOUTCOMES.112.966903 10.1161/HYPERTENSIONAHA.117.09633 10.1016/j.jacc.2009.08.058 10.1016/j.jacc.2011.06.024 10.1177/1358863X17725809 10.1111/j.1743-6109.2010.01792.x 10.1007/s00345-018-2318-3 10.1177/2047487318778994 10.1001/jama.2011.336 10.1161/CIR.0b013e3182447787 10.1161/CIRCULATIONAHA.114.012709 10.1016/j.apnr.2015.04.011 10.1016/j.amjmed.2019.06.019 10.1016/j.jsxm.2017.04.673 10.1136/heartjnl-2015-308993 10.1136/heartjnl-2012-302305 10.1177/1474515112473528 10.1016/j.hrtlng.2006.12.001 10.1002/ehf2.12014 10.2174/1570161115666170609101502 10.2164/jandrol.04191 10.1097/HJH.0000000000000519 10.1093/ehjci/ehaa946.2797 10.1111/j.1743-6109.2012.02998.x 10.1097/HJH.0000000000001052 10.1016/j.jsxm.2018.12.007 10.1016/j.jsxm.2019.11.256 10.1007/s10557-021-07197-9 10.1016/j.ehj.2003.08.016 10.1111/j.1745-7262.2006.00076.x 10.1124/jpet.107.135681 10.1038/ijir.2008.28 10.1016/S0090-4295(02)02114-3 10.1056/NEJMoa030656 10.1161/01.HYP.29.1.8 10.1007/s12471-013-0482-z 10.1111/j.1365-2710.1996.tb00006.x 10.1016/j.amjmed.2017.10.043 10.1097/HJH.0b013e3283050886 10.1097/00005392-199805000-00033 10.1038/sj.bjp.0702229 10.1002/phar.2391 10.1111/and.12784 10.1038/sj.ijir.3901516 10.1007/s11154-019-09535-7 10.3390/nu13010108 10.1001/archinternmed.2011.440 10.1016/j.jsxm.2018.02.008 10.1093/eurheartj/eht270 10.1016/j.mayocp.2012.06.015 10.1016/j.sxmr.2018.03.008 10.1016/j.amjcard.2005.03.097 10.1177/1074248418771896 10.1111/j.1743-6109.2011.02537.x 10.1001/jama.2013.2024 10.1111/j.1743-6109.2008.01107.x 10.1016/j.amjhyper.2004.06.027 10.1191/1358863x03vm509ra 10.1016/j.ijcard.2014.12.072 10.1016/j.amjcard.2005.06.091 10.1136/heartjnl-2017-312865 10.1111/bph.14920 10.1136/heartjnl-2016-310746 10.1016/j.jacc.2021.01.045 10.1136/heartjnl-2015-309223 10.1111/ijcp.12779 10.1371/journal.pone.0085805 10.1038/s41569-019-0211-4 10.1016/j.atherosclerosis.2016.04.018 10.1016/j.atherosclerosis.2013.12.010 10.1056/NEJMoa1000485 10.1001/jama.2016.21043 10.1001/jama.2015.8881 10.1159/000351696 10.1080/13685530312331309752 10.1038/sj.ijir.3901174 10.1038/sj.ijir.3901604 10.4065/84.2.108 10.1111/j.1743-6109.2009.01354.x 10.1111/j.1743-6109.2010.01973.x 10.1111/jsm.12918 10.1111/jsm.13032 10.1161/CIRCULATIONAHA.118.033990 10.1016/j.annepidem.2005.06.047 10.1111/j.1743-6109.2005.20230.x 10.1111/j.1440-1681.2007.04551.x 10.1111/j.1755-5922.2009.00123.x 10.1097/00004872-199301000-00015 10.1159/000350955 10.1001/archinte.1991.00400120048008 10.1016/S0149-2918(03)80282-5 10.1097/HJH.0b013e3283455ca5 10.1038/ijir.2009.48 10.1016/j.cjca.2017.09.026 10.1111/j.1464-410X.2012.11241.x
Nature Reviews. Cardiology; Terentes-Printzios D, Ioakeimidis N et. al.

Aug 1st, 2021 - Sexual health has a fundamental role in overall health and well-being, and a healthy and dynamic sex life can make an important contribution to a good quality of life. Sexual dysfunction, and especially erectile dysfunction (ED) in men, is highly ...

Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction...
https://doi.org/10.1016/j.jcyt.2021.06.001
Cytotherapy You D, Jang MJ et. al.

Jul 31st, 2021 - The efficacy of phosphodiesterase type 5 inhibitors (PDE5Is), which are commonly used to treat erectile dysfunction (ED), is not satisfactory in patients with denervation of the cavernous nerve due to pelvic surgeries and diabetes mellitus (DM). P...

Erectile Dysfunction and Partner-Directed Behaviors in Romantic Relationships: The Medi...
https://doi.org/10.1080/00224499.2021.1956412
Journal of Sex Research; Vance G, Zeigler-Hill V et. al.

Jul 29th, 2021 - Erectile dysfunction (ED) has been shown to have a considerable impact on romantic relationships. The purpose of the present research was to examine whether the associations that ED had with men's mate retention behaviors, partner-directed insults...

Peptide amphiphile nanofiber hydrogel delivery of sonic hedgehog protein to the penis a...
https://doi.org/10.1016/j.nano.2021.102444
Nanomedicine : Nanotechnology, Biology, and Medicine; Martin S, Harrington DA et. al.

Jul 28th, 2021 - Erectile dysfunction (ED) is a common and debilitating condition with high impact on quality of life. An underlying cause of ED is apoptosis of penile smooth muscle, which occurs with cavernous nerve injury, in prostatectomy, diabetic and aging pa...

Abrupt-onset, profound erectile dysfunction in a healthy young man after initiating ove...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305519
Journal of Medical Case Reports; Perry TW

Jul 25th, 2021 - Proton pump inhibitors are frequently used (and often overused) medications with adverse effects including vitamin B12 deficiency, Clostridium difficile colitis, and increased risk of chronic kidney disease. Erectile dysfunction is largely unrecog...

see more →

Guidelines  10 results

My Treatment Approach to Multiple System Atrophy.
https://doi.org/10.1016/j.mayocp.2020.10.005
Mayo Clinic Proceedings; Coon EA, Ahlskog JE

Mar 7th, 2021 - Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a tertiary care center. The long-term manage...

British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunctio...
https://doi.org/10.1016/j.jsxm.2018.01.023
The Journal of Sexual Medicine; Hackett G, Kirby M et. al.

Mar 20th, 2018 - This is an update of the 2008 British Society for Sexual Medicine (BSSM) guidelines. To provide up-to-date guidance for U.K. (and international) health care professionals managing male sexual dysfunction. Source information was obtained from peer-...

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From ...
https://doi.org/10.1016/j.jsxm.2016.11.324
The Journal of Sexual Medicine; Salonia A, Adaikan G et. al.

Mar 7th, 2017 - Sexual dysfunction is common in patients after radical prostatectomy (RP) for prostate cancer. To provide the International Consultation for Sexual Medicine (ICSM) 2015 recommendations concerning management strategies for post-RP erectile function...

Erectile dysfunction.
https://doi.org/10.1016/j.jcjd.2013.01.041
Canadian Journal of Diabetes; , Brock G et. al.

May 16th, 2014 - Erectile dysfunction.|2014| ,Brock G,Harper W,|diagnosis,prevention & control,therapy,diagnosis,prevention & control,therapy,

Survivorship: sexual dysfunction (male), version 1.2013.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465261
Journal of the National Comprehensive Cancer Network : JN... Denlinger CS, Carlson RW et. al.

Mar 13th, 2014 - Various anticancer treatments, especially those directed toward the pelvis, can damage blood vessels and reduce circulation of blood to the penis and/or damage the autonomic nervous system, resulting in higher rates of erectile dysfunction in surv...

see more →

Drugs  260 results see all →

Clinicaltrials.gov  199 results

MR Image Guided Therapy in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT01377753

May 6th, 2020 - Background: Pilot study is designed to evaluate the safety and feasibility of thermal laser ablation of focal prostate tumors. Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostat...

Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.
https://clinicaltrials.gov/ct2/show/NCT03317990

Feb 25th, 2020 - Prostate cancer is very common and results in the death of many men in the developed world. Prostate cancer that has not spread outside the prostate can usually be cured by surgical removal of the prostate gland (radical prostatectomy). Radical Pr...

Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
https://clinicaltrials.gov/ct2/show/NCT02495467

Feb 12th, 2020 - This randomised, double-blind, placebo-controlled cross-over study is designed to evaluate the efficacy and safety of MED2005, a topically applied glyceryl trinitrate (GTN) gel administered to the penis of male subjects immediately before sexual i...

Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT01238224

Feb 12th, 2020 - An increase of blood flow and capillary permeability decrease the impact of an endothelial barrier for glucose and insulin allowing them to reach their target cells in peripheral insulin sensitive organ in the human body. It is well known that ins...

Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)
https://clinicaltrials.gov/ct2/show/NCT03703778

Jan 27th, 2020 - The prostate gland is a clinically important male accessory sex gland and vital for its production of semen. Prostate cancer (PCa) is now ranked 3th in annual incidence of male cancer and ranked 5th for cancer-related death in men in Hong Kong whi...

see more →

News  528 results

Dulaglutide Tied to Lower Incidence of Erectile Dysfunction in Type 2 Diabetes
https://www.medscape.com/viewarticle/954532

Jul 12th, 2021 - NEW YORK (Reuters Health) - Men with type 2 diabetes randomly assigned to dulaglutide versus placebo had a lower incidence of erectile dysfunction, an exploratory analysis showed. "The finding that dulaglutide reduced the occurrence of moderate or...

New AHA Statement Urges Attention to Sleep Apnea
https://www.medscape.com/viewarticle/953527?src=sapfe

Jun 22nd, 2021 - Obstructive sleep apnea (OSA) is common in patients with cardiovascular disease (CVD), yet it is often under-recognized and treated in cardiovascular practice, the American Heart Association (AHA) says in a new scientific statement. "Obstructive s...

Yamtun7 Issues Voluntary Nationwide Recall of Poseidon Platinum 3500 Due to the Presence of Undeclared Tadalafil and Sildenafil | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/yamtun7-issues-voluntary-nationwide-recall-poseidon-platinum-3500-due-presence-undeclared-tadalafil

Summary Company Announcement Date: May 11, 2021 FDA Publish Date: May 11, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Undeclared Tadalafil and Sildenafil Company Name: Yamtun7 Brand Name: Brand Name(s) Poseidon Prod...

Former British Cycling Doctor to Appeal Against Testosterone Doping Ruling
https://www.medscape.com/viewarticle/949811

Apr 23rd, 2021 - Former Team Sky and British Cycling doctor Richard Freeman has launched an appeal after being found guilty of ordering testosterone for doping purposes. A Medical Practitioners Tribunal reached that verdict at the end of a long-running hearing in ...

Yolo Studio Issues Voluntary Nationwide Recall of PremierZEN Extreme 3000, PremierZEN Black 5000, & Triple SupremeZEN Plus 3500 Due to the Presence of Undeclared Tadalafil | FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/yolo-studio-issues-voluntary-nationwide-recall-premierzen-extreme-3000-premierzen-black-5000-triple

Summary Company Announcement Date: April 05, 2021 FDA Publish Date: April 06, 2021 Product Type: Drugs Reason for Announcement: Recall Reason Description Undeclared Tadalafil Company Name: Yolo Studio Brand Name: Brand Name(s) PremierZEN Extreme 3...

see more →

Patient Education  29 results see all →